Ecolab Inc. (ECL)
NYSE: ECL · Real-Time Price · USD
238.29
+2.76 (1.17%)
Dec 20, 2024, 4:00 PM EST - Market closed

Ecolab Revenue by Segment

Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021
Industrial
7.63B 7.47B 7.34B 7.21B 7.12B 7.07B 6.95B 6.81B
Industrial Growth
7.14% 5.66% 5.62% 5.91% 6.59% 8.43% 9.04% 9.09%
Institutional and Specialty
5.32B 5.23B 5.14B 4.99B 4.83B 4.69B 4.54B 4.42B
Institutional and Specialty Growth
10.11% 11.50% 13.04% 12.90% 11.09% 10.09% 10.61% 11.84%
Healthcare and Lifesciences
1.52B 1.58B 1.58B 1.48B 1.47B 1.43B 1.43B 1.51B
Healthcare and Lifesciences Growth
3.11% 10.96% 10.95% -1.99% 4.32% 6.45% 14.04% 27.84%
Other
1.24B 1.31B 1.38B 1.44B 1.41B 1.39B 1.36B 1.32B
Other Growth
-12.21% -5.27% 1.40% 8.93% 8.46% 8.65% 9.53% 8.67%
Corporate
- - - 69.00M 82.80M 67.80M 51.10M 62.20M
Corporate Growth
- - - 10.93% - - -63.71% -55.32%

Operating Income by Segment

Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021
Industrial
1.24B 1.18B 1.13B 1.08B 1.03B 1.01B 978.10M 951.50M
Industrial Growth
21.04% 17.15% 15.27% 13.53% 7.55% 5.83% -1.31% -6.74%
Institutional and Specialty
1.13B 1.06B 943.40M 821.30M 749.30M 695.50M 638.80M 623.80M
Institutional and Specialty Growth
50.91% 51.70% 47.68% 31.66% 21.74% 13.50% 6.47% 13.19%
Other
242.50M 252.30M 252.90M 254.30M 242.50M 232.60M 220.80M 208.50M
Other Growth
- 8.47% 14.54% 21.97% 23.91% 21.53% 15.30% 11.80%
Healthcare and Lifesciences
154.30M 162.50M 161.50M 159.70M 172.90M 160.30M 184.40M 193.50M
Healthcare and Lifesciences Growth
-10.76% 1.37% -12.42% -17.47% 7.26% -3.55% 17.15% 22.39%
Corporate
82.60M -291.10M -291.90M -289.50M -371.30M -355.60M -362.50M -414.80M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.